Evidence map›Paper›PMID 32386354›Full record

ArticleDrug testing and analysis2020

Can dried blood spots (DBS) contribute to conducting comprehensive SARS-CoV-2 antibody tests?

Mario Thevis, Andre Knoop, Maximilian S Schaefer, Bertin Dufaux, Yvonne Schrader, Andreas Thomas, Hans Geyer

Abstract readLetter
In one paragraph

Article in Drug testing and analysis, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 23 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
23citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

23 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Trial
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Expanding access to SARS-CoV-2 IgG and IgM serologic testing using fingerstick whole blood, plasma, and rapid lateral flow assays.Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology · 2021
    Article
  15. Article
  16. A high-throughput microfluidic nanoimmunoassay for detecting anti-SARS-CoV-2 antibodies in serum or ultralow-volume blood samples.Proceedings of the National Academy of Sciences of the United States of America · 2021
    Article
  17. Article
  18. Use of dried blood spot samples for SARS-CoV-2 antibody detection using the Roche Elecsys ® high throughput immunoassay.Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology · 2021
    Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Mario ThevisCenter for Preventive Doping Research - Institute of Biochemistry, German Sport University Cologne, Cologne, Germany.ORCID https://orcid.org/0000-0002-1535-6451
Andre KnoopCenter for Preventive Doping Research - Institute of Biochemistry, German Sport University Cologne, Cologne, Germany.
Maximilian S SchaeferDepartment of Anesthesia, Critical Care & Pain Medicine, Beth Israel Deaconess Medical Center & Harvard Medical School, Boston, MA, USA.
Bertin DufauxMVZ Labor Krone GbR, Bad Salzuflen, Germany.
Yvonne SchraderCenter for Preventive Doping Research - Institute of Biochemistry, German Sport University Cologne, Cologne, Germany.
Andreas ThomasCenter for Preventive Doping Research - Institute of Biochemistry, German Sport University Cologne, Cologne, Germany.ORCID https://orcid.org/0000-0003-1199-0743
Hans GeyerCenter for Preventive Doping Research - Institute of Biochemistry, German Sport University Cologne, Cologne, Germany.

Funding

Federal Ministry of the Interior, Building and Community
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Dried Blood Spot TestingEnzyme-Linked Immunosorbent AssaySerologic TestsAntibodies, ViralBetacoronavirusBiomarkersClinical Laboratory TechniquesCoronavirus InfectionsCOVID-19COVID-19 TestingHumansImmunoglobulin GImmunoglobulin MPandemicsPilot ProjectsPneumonia, ViralAntibodies, ViralBiomarkersImmunoglobulin GImmunoglobulin M

Identifiers

PMID32386354
PMCPMC7272963

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.